Gennova sees uptick in its Omicron-specific Covid booster

Credit: IndiaTimes- Published on December 28, 2023
Pune-based Gennova Biopharmaceuticals witnessed demand for its Omicron-specific Covid-19 vaccine, Gemcovac-OM, due to the recent surge in cases. Gemcovac-OM is India's first mRNA-based vaccine approved against the JN.1 variant. Priced at Rs 2299, it is available in 70 centers across metros and certain cities. The JN.1 variant is...

You are here


💡 newsR Knowledge: Other News Mentions

COVID-19

Contagious disease caused by SARS-CoV-2
Two companies are being sued by the British government for over £145m after they allegedly supplied defective COVID-19 tests.
Credit: Sky News - Published 10 hours ago

A dad who suffered a brain injury just days after receiving a British-developed COVID vaccine has told Sky News he would never have had the jab if he had known..
Credit: Sky News - Published 1 day ago

Baba Ramdev crossed a red line when he claimed he could cure Covid-19 and at the same time maligned modern medicine by calling it a "stupid and bankrupt..
Credit: IndiaTimes - Published 1 day ago

Speaking at an event in Delhi's Kirori Mal College, Jaishankar emphasized that India's handling of the Covid-19 pandemic and the success of the Chandrayaan-3..
Credit: IndiaTimes - Published 2 days ago


Pune

Metropolis in Maharashtra, India
The inauguration of the nation's inaugural Constitution Park took place recently in Pune.
Credit: DNA - Published 12 hours ago


Messenger RNA

RNA that is read by the ribosome to produce a protein
The world's first personalised mRNA cancer jab for melanoma is being tested in British patients.
Credit: Sky News - Published 5 days ago

You might like